Clinical trials
Withdrawn Phase 2 Parkinson Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2012 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oregon Health and Science University | 2 |
| Andrew Newberg | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Biogen | 1 |
| Department of Medical Services Ministry of Public Health of Thailand | 1 |
| Eisai Inc. | 1 |
| Forest Hills Lab | 1 |
| Intec Pharma Ltd. | 1 |
| Jazz Pharmaceuticals | 1 |
| King's College London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 16 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Central Nervous System Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Disorders of Excessive Somnolence | 1 |
| Dyskinesias | 1 |
| Fatigue | 1 |
| Movement Disorders | 1 |
| Multiple Sclerosis | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.